Budes 64 Mikrogramm/Sprühstoß Nasenspray clinical trials

A prospective, randomized, double-blind placebo-controlled multicentre trial with mannan-conjugated birch pollen allergoids administered subcutaneously to adolescents and adults with birch pollen-induced allergic rhinitis or rhinoconjunctivitis.

This study is looking into a new treatment for birch pollen allergy. It compares a new vaccine-like medicine given by injection to a dummy treatment. The aim is to see if the new medicine can help reduce symptoms like sneezing and itchy eyes during pollen season.